Finch Therapeutics Group Overview

Finch Therapeutics Group EBIT

EBIT (Earnings Before Interest and Taxes) analysis for FNCH.

Quarterly EBIT

-$6.11M

↑ 37.57% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$19.79M

↑ 31.26% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin